Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Evaluating the efficacy of mySugr in a randomized controlled trial : Baseline characteristics

Publication

Evaluating the efficacy of mySugr in a randomized controlled trial : Baseline characteristics

Ehrmann, Dominic; Kulzer, Bernhard; Silbermann, Stephan; u. a. (2023): Evaluating the efficacy of mySugr in a randomized controlled trial : Baseline characteristics, in: Diabetes technology and therapeutics, Larchmont, NY: Mary Ann Liebert Inc, S. A66, doi: 10.1089/dia.2023.2525.abstracts.

Details

Faculty/Chair
Faculty/Professorship
Author
ORCID iDEhrmann, Dominic; Kulzer, Bernhard; Silbermann, Stephan; Kober, J.; Finke-Gröne, Katharina; Roos, Timm; Vesper, Iris; Schäfer, V.; ORCID iDHermanns, Norbert
Title of the Journal
Diabetes technology and therapeutics
ISSN
1557-8593
Corporate Body
Advanced Technologies & Treatments for Diabetes ATTD
Conference
ATTD 16th International Conference on Advanced Technologies and Treatments for Diabetes. 22-25 February 2023, Berlin, Germany
Publisher Information
Mary Ann Liebert Inc : Larchmont, NY
Year of publication
2023
Volume
25
Issue
S2
Language
English
DOI
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
no
Type
Conferenceobject
URI
Activation date
2024-09-02

Permalink: https://fis.uni-bamberg.de/handle/uniba/97778 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.